Technical Confirmation Process

From QIBA Wiki
Revision as of 20:55, 24 January 2011 by Abuckler (Talk | contribs) (New page: The purpose of this process step is to collect feedback on use of the document. Whereas the review and public comment steps prior to this focused on the document itself, this step now see...)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

The purpose of this process step is to collect feedback on use of the document. Whereas the review and public comment steps prior to this focused on the document itself, this step now seeks feedback on initial use of it given that it has been placed into trial implementation. As such, comments are solicited specifically from those that have used it and only those that have used it.

A procedure is outlined below listing what is done (by whom).


Period: 30 days

  • Collect list of people that have participated in the field test (leader of field test)
  • Finalize comment form that will be used in the survey (secretariat with technical committee)
  • Send announcement to mailing lists (secretariat)
  • Email comments to Field Test leader (Commenters)
    • commenters include full range of users of the document, e.g., clinical oncologists, imaging scientists, pharma, CRO’s, etc. However, only people who have used document are included.
    • please use the provided comment form
  • Collate all comments into a spreadsheet (secretariat/Field Test leader)
    • Summarize range of feedback to the questions into a report for review by the technical committee provided by the Field Test leader.
    • Technical Committee decides what changes to make (if any) to the document and whether to refer it to the Modality Committee for publication, whether to conduct another round of field test, or to place the document into an inactive status
  • Record resolution in spreadsheet
    • Regardless of recommended status for this document, ensure that the results are made available to related activities